Dietrich John Pauls Dia Medica Therapeutics Inc. (DMAC) insider trading activity

DMAC Quotes by TradingView

Dietrich John Pauls is President and CEO of DiaMedica Therapeutics Inc.. Currently has a direct ownership of 68,591 shares of DMAC, which is worth approximately $276,421. The most recent transaction as insider was on Jun 23, 2023, when has been sold 12,787 shares (Voting Common Shares, no par value per share) at a price of $3.91 per share, resulting in proceeds of $49,997. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 68.6K
0% 3M change
0% 12M change
Total Value Held $276,421

Dietrich John Pauls Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 23 2023
BUY
Open market or private purchase
$49,997 $3.91 p/Share
12,787 Added 15.71%
68,591 Voting Common Shares, ...
Nov 16 2022
BUY
Open market or private purchase
$24,200 $1.21 p/Share
20,000 Added 26.38%
55,804 Voting Common Shares, ...
Aug 16 2021
BUY
Open market or private purchase
$15,700 $3.14 p/Share
5,000 Added 12.25%
35,804 Voting Common Shares, ...
DJP

Dietrich John Pauls

President and CEO
Minneapolis, MN

Track Institutional and Insider Activities on DMAC

Follow DiaMedica Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DMAC shares.

Notify only if

Insider Trading

Get notified when an Dia Medica Therapeutics Inc. insider buys or sells DMAC shares.

Notify only if

News

Receive news related to DiaMedica Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DMAC